# Obesity results in lower integrin expression in women with polycystic ovarian syndrome during the window of implantation

**Authors:** Fazilah Abdul Hamid, Mohd Helmy Mokhtar, Abdul Kadir Abdul Karim, Mohd Faizal Ahmad, Nor Haslinda Abd Aziz, Azantee Yazmie Abdul Wahab, Muhammad Azrai Abu

PMC · DOI: 10.3389/fendo.2025.1590716 · Frontiers in Endocrinology · 2025-10-21

## TL;DR

Obesity in women with PCOS reduces integrin expression during implantation, which may affect fertility.

## Contribution

The study reveals a novel link between obesity in PCOS and reduced αvβ3 integrin expression during the implantation window.

## Key findings

- Obese PCOS women showed significantly lower αvβ3-integrin mRNA expression compared to non-obese PCOS and control groups.
- Mucin-1 and E-cadherin expression levels were not significantly different across the groups.
- Reduced integrin expression in obese PCOS may impact implantation and fertility.

## Abstract

Polycystic ovary syndrome (PCOS) is a common endocrine disorder that is characterized by hormonal imbalances and ovarian dysfunction. Obesity is also a prevalent issue that has been linked to the development of PCOS. The present study aimed to investigate the gene expression of αvβ3 integrin, mucin-1, and E-cadherin in obese and non-obese women with and without PCOS.

This prospective study was undertaken at the Advanced Reproductive Centre at Hospital Canselor Tuanku Muhriz (Universiti Kebangsaan Malaysia) from January 2019 to June 2021. A total of 40 women were recruited for the study and divided equally (n = 10) into four groups, namely, i) control with normal body weight, ii) control obese, iii) PCOS with normal body weight, and iv) PCOS obese. An endometrial tissue sample was collected after 10 days of daily oral micronized progesterone (Utrogestan 200 mg) in the PCOS group. In the fertile or control group, midsecretory phase endometrial biopsy was performed following 7 days post-ovulation. Then, total RNA was isolated from the endometrial tissue. Gene expression was analyzed using RT-qPCR.

The results showed that the mRNA expression of αVβ3-integrin was significantly decreased in the PCOS obesity group compared to the PCOS normal body weight group and the control normal body weight group. No significant differences were observed in mucin-1 and E-cadherin expression between the groups.

αvβ3 integrin plays an important role in the development of the window of implantation in obese PCOS individuals. Further research is needed to confirm these results and to identify the potential mechanisms underlying this association.

ClinicalTrial.gov, identifier NCT04175002.

## Linked entities

- **Genes:** Muc1 (mucin 1, cell surface associated) [NCBI Gene 100772836], shg (shotgun) [NCBI Gene 37386]
- **Chemicals:** Utrogestan (PubChem CID 5994)
- **Diseases:** Polycystic ovary syndrome (MONDO:0008487), Obesity (MONDO:0011122)

## Full-text entities

- **Genes:** CDH1 (cadherin 1) [NCBI Gene 999] {aka Arc-1, BCDS1, CD324, CDHE, ECAD, LCAM}, MUC1 (mucin 1, cell surface associated) [NCBI Gene 4582] {aka ADMCKD, ADMCKD1, ADTKD2, CA 15-3, CD227, Ca15-3}
- **Diseases:** endocrine disorder (MESH:D004700), ovarian dysfunction (MESH:D010049), PCOS (MESH:D011085), Obesity (MESH:D009765)
- **Chemicals:** progesterone (MESH:D011374), Utrogestan (MESH:C000624167)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12583220/full.md

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12583220/full.md

## References

26 references — full list in the complete paper: https://tomesphere.com/paper/PMC12583220/full.md

---
Source: https://tomesphere.com/paper/PMC12583220